● Recruiting

Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer

Condition: Ovarian Cancer, Epithelial · Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon

PhasePhase 2

Planned participants84

Who can joinFemale, 18 Years to 75 Years

Healthy volunteersNo

About this study

CHIMOVIP is a study to determine the best therapeutic strategy in patient with ovarian advanced cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Richard VILLET, MD · 33 (0) 1 44 74 10 42

Delphine COCHEREAU, MD

Always discuss trial participation with your own doctor first.

Locations (7)

Centre Georges François Leclerc	Dijon, France	Recruiting
Institut Hospitalier Franco-Britannique	Levallois-Perret, France	Recruiting
Groupe Hospitalier Diaconesses Croix Saint Simon	Paris, France	Recruiting
Hôpital Saint Antoine	Paris, France	Recruiting
Hôpital Poissy Saint Germain	Poissy, France	Recruiting
CHU Poitiers	Poitiers, France	Recruiting
Centre Hospitalier Senlis	Senlis, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03025477